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Fetal hematopoiesis occurs in mul-
tiple embryonic niches including the 
yolk sac, the AGM (aorta-gonad-
mesonephros) region, and the fetal 
liver during development. In contrast, 
adult hematopoiesis occurs primarily 
in bone marrow. Fetal and adult hema-
topoietic stem cells (HSCs) express 
different surface markers and the fetal 
HSC pool expands rapidly in the fetal 
liver, whereas most adult HSCs are 
quiescent (Mikkola and Orkin, 2006). 
Although several transcriptional reg-
ulators—including Gfi-1 (Hock et al., 
2004a), Tel/Etv6 (Hock et al., 2004b), 
and Bmi-1 (Park et al., 2003)—main-
tain adult (but not fetal) HSCs, little 
is known about regulators that exclu-
sively maintain fetal HSCs. In this 
issue, Kim et al. (2007) demonstrate 
in the mouse that the expression of 
a well-known transcription factor and 
endodermal marker, Sox17, is tightly 
restricted to fetal and neonatal HSCs 
and is required for their maintenance 
but not that of adult HSCs (Kim et al., 
2007) (Figure 1A).
Based upon gene expression 
profiles of fetal versus adult mouse 
HSCs, Kim et al. (2007) found that 
Sox17 was specifically expressed in 
fetal HSCs. Virtually all fetal HSCs 
expressed Sox17, whereas the per-
centage of Sox17-expressing post-
natal HSCs in bone marrow gradually 
decreased, becoming undetectable 8 
weeks after birth. The lack of Sox17 
expression was not due to quies-
cence of adult HSCs, because Sox17 
expression was not induced in adult 
HSCs that had been artificially stim-
ulated to proliferate. These results 
exclude the possibility that Sox17 is 
simply expressed by dividing HSCs. 
Importantly, a severe defect in fetal 
hematopoiesis was observed in mice 
lacking Sox17. Knockout mouse 
embryos had fewer blood cells and 
progenitor cells capable of forming 
colonies in culture compared to wild-
type littermates.
Is Sox17 required for the genera-
tion of HSCs within the hematopoi-
etic and endothelial lineages? In mice 
carrying a Sox17 deletion specifically 
in endothelial and hematopoietic 
progenitor cells (Tie2-Cre+Sox17fl/GFP 
mice), the ability of blood cells in the 
yolk sac and embryo at embryonic 
day (E)11.5 that were able to reconsti-
tute the hematopoietic system after 
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What controls the inherent differences between fetal and adult hematopoietic stem cells (HSCs)? 
In this issue of Cell, Kim et al. (2007) demonstrate in mice that the endodermal transcription 
factor Sox17 is required for the maintenance of fetal and neonatal but not adult HSCs.
Figure 1. Regulation of Pre- and Postnatal Hematopoietic Stem Cells
(A) Transcriptional regulation of hematopoietic stem cells (HSCs) during mouse development. The 
genes depicted are required for formation or maintenance of HSCs. Genes (?) required for certain 
stages (white boxes) of HSC development have yet to be determined. 
(B) How Sox17 could promote the maintenance of fetal/neonatal HSCs. Sox17 deletion dramati-
cally increases expression of Dkk1 (a negative regulator of Wnt signaling) in hematopoietic pro-
genitors from embryos and neonatal bone marrow (Kim et al., 2007). Could overexpression of 
β-catenin be sufficient to maintain fetal/neonatal HSCs in the absence of Sox17? The role of fetal 
endodermal niches (i.e., fetal liver and yolk-sac endoderm) in the expression of Sox17 (an early 
endodemal marker) in fetal HSCs originating in the mesoderm is still not known.
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transplantation was greatly reduced. 
Sox17 is thus required in hematopoi-
etic and/or endothelial cells for the 
generation or maintenance of defini-
tive HSCs. What about the effect of 
this gene on hematopoietic progeni-
tor cell differentiation? Although the 
number of in vitro colonies derived 
from E11.5 Tie2-Cre+Sox17fl/GFP yolk-
sac cells was markedly reduced, the 
types of colonies, their appearance, 
and their composition were compa-
rable to colonies derived from control 
yolk-sac cells. All colonies from Tie2-
Cre+Sox17fl/GFPmice as well as con-
trol animals expressed adult, but not 
fetal, hemoglobin. Thus, hematopoi-
etic progenitors from Sox17-deficient 
mice differentiate normally, implying 
that Sox17 is not required for hema-
topoietic differentiation.
Conditional Sox17 depletion sev-
eral days after birth resulted in a 
marked reduction in the numbers of 
HSCs and colony-forming progeni-
tors in the bone marrow and spleen, 
indicating that Sox17 is also required 
for maintenance of neonatal HSCs. To 
further test if Sox17 is autonomously 
required for HSC maintenance, bone 
marrow cells were transplanted from 
conditional Sox17 knockout neonatal 
mice into irradiated wild-type recipi-
ents. There was long-term multilin-
eage reconstitution by control bone 
marrow cells, but not by bone mar-
row cells from Sox17-deficient mice. 
Furthermore, deletion of Sox17 from 
fetal HSCs engrafted in the marrow of 
wild-type mice resulted in a consid-
erable loss of reconstituting poten-
tial. These data indicate that Sox17 
is autonomously required for the 
maintenance of both fetal and neo-
natal HSCs. However, Sox17 is not 
required for adult HSC maintenance, 
proliferation, or mobilization. At 4 
weeks after birth, HSCs shift from a 
proliferating fetal phenotype to a qui-
escent adult phenotype (Bowie et al., 
2006). Using 4-week-old mice Kim 
et al. demonstrate that the loss of 
Sox17 expression is associated with 
the acquisition of a slowly dividing 
adult phenotype and the loss of fetal 
HSC surface markers. Thus, Sox17 
may serve as a marker of fetal iden-
tity in HSCs.
What are the molecular mecha-
nisms by which Sox17 promotes 
the maintenance of HSCs? Kim and 
colleagues found that Sox17 is not 
required for the expression of some 
genes involved in the formation or 
function of HSCs, including Runx1, 
Scl, or c-Myb, suggesting that Sox17 
works downstream of these genes. It 
would be interesting to see whether 
these transcription factors regulate 
Sox17 and whether Sox17 expres-
sion can rescue the induction or 
maintenance of HSCs in knockout 
mouse models such as Scl or Runx1 
null mice. In addition, the authors 
discovered that Sox17 deletion dra-
matically increased expression of 
Dkk1, a negative regulator of the Wnt 
signaling pathway, in hematopoietic 
progenitors from E11.5 embryos and 
neonatal bone marrow. This finding 
implies that Sox17 maintains fetal/
neonatal HSCs by promoting Wnt 
signaling (Figure 1B). It will be inter-
esting to determine whether enforced 
Wnt signaling would be sufficient to 
maintain fetal/neonatal HSCs in the 
absence of Sox17.
During human fetal hematopoi-
etic development, fetal liver stromal 
cells provide a unique microenvi-
ronment to HSCs by regulating Wnt 
signaling, whereas the bone marrow 
microenvironment for adult HSCs 
tightly regulates the Notch signaling 
pathway (Martin and Bhatia, 2005). 
However, it is not clear whether the 
role of Wnt signaling in human and 
mouse fetal hematopoietic develop-
ment is identical. It will be important 
to determine the precise regulation 
of Wnt signaling in association with 
Sox17 in both mouse and human 
fetal hematopoiesis.
Sox17 is required for the specifica-
tion and maintenance of the endo-
derm in the embryo (Hudson et al., 
1997; Kanai-Azuma et al., 2002). Fetal 
endoderm tissues such as yolk-sac 
endoderm and fetal liver stroma sup-
port fetal HSC growth and function 
(Yoder et al., 1994; Martin and Bha-
tia, 2005). These fetal endodermal 
niches may be closely linked to the 
Sox17 expression of fetal HSCs. It 
will be crucial to determine the cues 
from endodermal niches that trigger 
the acquisition of Sox17 expression 
(or maintain its expression) in fetal 
HSCs (Figure 1B) and which mol-
ecules downregulate Sox17 expres-
sion once HSCs migrate to the bone 
marrow. Additionally, although this 
study convincingly demonstrates the 
role of Sox17 in the maintenance of 
definitive HSCs throughout fetal and 
neonatal periods, it remains unclear 
how this gene is regulated during 
embryonic hematopoiesis before E11 
(Figure 1A). The earliest embryonic 
stage that requires Sox17 regulation 
of hematopoiesis is still unknown.
Kim et al. (2007) provide an impor-
tant regulatory mechanism to distin-
guish fetal and neonatal HSCs from 
adult HSCs. However, much remains 
to be learned about the transition 
from proliferative fetal HSCs to qui-
escent adult HSCs, a highly complex 
process that is likely to require an 
orchestra of different players. Future 
elucidation of Sox17 coactivators 
and downstream effecter molecules 
will enhance our understanding of 
this process.
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